0001093557-23-000136.txt : 20230522
0001093557-23-000136.hdr.sgml : 20230522
20230522154745
ACCESSION NUMBER: 0001093557-23-000136
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230518
FILED AS OF DATE: 20230522
DATE AS OF CHANGE: 20230522
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Malady Kyle
CENTRAL INDEX KEY: 0001760581
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51222
FILM NUMBER: 23944255
MAIL ADDRESS:
STREET 1: 1095 AVENUE OF THE AMERICAS
CITY: NEW YORK
STATE: NY
ZIP: 10036
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DEXCOM INC
CENTRAL INDEX KEY: 0001093557
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330857544
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6340 SEQUENCE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8582000200
MAIL ADDRESS:
STREET 1: 6340 SEQUENCE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0407
4
2023-05-18
0
0001093557
DEXCOM INC
DXCM
0001760581
Malady Kyle
6340 SEQUENCE DRIVE
SAN DIEGO
CA
92121
1
0
0
0
0
Common Stock
2023-05-18
4
A
0
2885
0.001
A
15529
D
The RSU Award was granted on May 18, 2023 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2024 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement.
Included in this number are 4,581 unvested restricted stock units, 2,885 of which were granted on May 18, 2023 and shall vest on the earlier of the one year anniversary of the grant or the date of DexCom Inc's 2024 Annual Meeting and 1,696 of which were granted on October 11, 2020 and shall vest through October 11, 2023.
By: Jereme Sylvain For: Kyle Malady
2023-05-22